CSIMarket



China Biologic Products Holdings Inc   (CBPO)
Other Ticker:  
 

Cumulative China Biologic Products Holdings Inc 's Working Capital Ratio for Trailing Twelve Months Period

CBPO's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

CBPO Working Capital Ratio for Trailing Twelve Months Period

(Dec 31 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Current Liabilities Growth -2.48 % -2.48 % -2.48 % -2.48 % 25.31 %
Y / Y Current Assets Growth -4.23 % -4.23 % -4.23 % -4.23 % 128.82 %
Working Capital Ratio for Trailing Twelve Months Period 10.89 10.94 10.99 11.04 11.09
Total Ranking # 284 # # # # 187
Seq. Current Liabilities Growth 0 % 0 % 0 % -2.48 % 0 %
Seq. Current Assets Growth 0 % 0 % 0 % -4.23 % 0 %


Working Capital Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite year on year decrease in China Biologic Products Holdings Inc 's average Current Liabilities to $119 millions, Working Capital Ratio for Trailing Twelve Months Period to 10.89 below company average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 27 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than China Biologic Products Holdings Inc . While Working Capital Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from to 284.

What is Working Capital Ratio?
More about CBPO
Working Capital Ratio CBPO in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 28
Sector # 105
S&P 500 # 270


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
11.09 5.2 2.46
(Dec 31 2018)   (March 31, 2015)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2019, within Biotechnology & Pharmaceuticals Industry Working Capital Ratio for Trailing Twelve Months Period
Neoleukin Therapeutics Inc.  23.69 
Eidos Therapeutics Inc   22.11 
Oyster Point Pharma Inc.  19.96 
G1 Therapeutics Inc.  19.92 
Iovance Biotherapeutics inc.  18.11 
Satsuma Pharmaceuticals Inc.  17.35 
Lixte Biotechnology Holdings Inc.  17.04 
Relmada Therapeutics Inc.  16.35 
Audentes Therapeutics Inc   16.04 
Axcella Health Inc.  15.51 
Quince Therapeutics Inc.  15.46 
Acceleron Pharma inc  15.37 
Adverum Biotechnologies Inc.  15.00 
Voyager Therapeutics Inc.  14.98 
Casi Pharmaceuticals inc.  14.10 
Clementia Pharmaceuticals Inc.  14.03 
Strongbridge Biopharma plc  13.93 
Homology Medicines Inc  13.79 
Cnbx Pharmaceuticals Inc.  13.66 
Nexien Biopharma Inc.  13.42 
Crispr Therapeutics Ag  13.30 
Infinity Pharmaceuticals Inc.  12.73 
Pulse biosciences inc.  12.44 
Regenxbio Inc.  12.41 
Organovo Holdings Inc.  12.14 
Biomx Inc.  12.08 
Aptose Biosciences Inc.  11.94 
Scpharmaceuticals Inc.  11.83 
Replimune Group Inc.  11.79 
Myokardia Inc   11.78 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ASCB's Profile

Stock Price

ASCB's Financials

Business Description

Fundamentals

Charts & Quotes

ASCB's News

Suppliers

ASCB's Competitors

Customers & Markets

Economic Indicators

ASCB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071